lupenone has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X; Wang, Y; Wu, H; Xu, F; Yang, Y; Zhang, M | 1 |
| Qian, H; Wang, X; Wang, Y; Wu, H; Xu, F; Yang, Y; Zhang, Y | 1 |
2 other study(ies) available for lupenone and Alloxan Diabetes
| Article | Year |
|---|---|
Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Insulin Resistance; Male; Network Pharmacology; Rats; Rats, Sprague-Dawley; Triterpenes | 2022 |
RP-HPLC characterization of lupenone and β-sitosterol in rhizoma musae and evaluation of the anti-diabetic activity of lupenone in diabetic Sprague-Dawley rats.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Hypoglycemic Agents; Limit of Detection; Male; Musa; Plant Extracts; Rats, Sprague-Dawley; Rhizome; Sitosterols; Triterpenes | 2014 |